TGFB1 and metabolic dysfunction-associated steatohepatitis: Additionally, CME treatment led to a significant reduction in the mRNA levels of pro-inflammatory cytokines TNF-α, IL-6, IL-1β, and TGF-β, which are known to play pivotal roles in the pathogenesis of NASH.